- Home
- VERA
as of 12-12-2025 3:43pm EST
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | BRISBANE |
| Market Cap: | 1.5B | IPO Year: | 2021 |
| Target Price: | $67.67 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.53 - $50.09 | Next Earning Date: | 11-05-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered VERA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Vera Therapeutics Inc. (VERA)
Chief Regulatory Officer
Avg Cost/Share
$45.31
Shares
10,000
Total Value
$453,053.00
Owned After
22,500
SEC Form 4
Chief Regulatory Officer
Avg Cost/Share
$40.00
Shares
10,000
Total Value
$400,000.00
Owned After
22,500
SEC Form 4
Chief Legal Officer
Avg Cost/Share
$27.82
Shares
3,864
Total Value
$107,498.03
Owned After
49,136
SEC Form 4
SVP, FINANCE, CHIEF ACCT OFFCR
Avg Cost/Share
$29.06
Shares
15,000
Total Value
$435,874.50
Owned After
47,839
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Turner William D. | VERA | Chief Regulatory Officer | Dec 8, 2025 | Sell | $45.31 | 10,000 | $453,053.00 | 22,500 | |
| Turner William D. | VERA | Chief Regulatory Officer | Dec 3, 2025 | Sell | $40.00 | 10,000 | $400,000.00 | 22,500 | |
| Carter Jason S | VERA | Chief Legal Officer | Nov 21, 2025 | Sell | $27.82 | 3,864 | $107,498.03 | 49,136 | |
| Young Joseph R | VERA | SVP, FINANCE, CHIEF ACCT OFFCR | Nov 11, 2025 | Sell | $29.06 | 15,000 | $435,874.50 | 47,839 |
Compare VERA vs Leading Stocks
See how VERA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "VERA Vera Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.